3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
5
Uterine Cervical Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Neoplasm Metastasis
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Ovarian Neoplasms
1
Neoplasms
1
Melanoma
1
Kidney Neoplasms
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Cystadenocarcinoma, Serous
1
Colorectal Neoplasms
1
Clear-cell metastatic renal cell carcinoma
1
Carcinosarcoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Merkel Cell
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Advanced Renal Cell Carcinoma (RCC)
1
Advanced Non-small Cell Lung Cancer
1
Adenocarcinoma, Mucinous
1
Interventions
Rituximab
9
ibrutinib
6
acalabrutinib
6
Cyclophosphamide
6
zanubrutinib
4
venetoclax
4
fludarabine phosphate
3
fludarabine
3
Whole-Body Irradiation
3
Methotrexate
3
Magnetic Resonance Spectroscopy
3
Cytarabine
3
Cyclosporine
3
CT-P10
3
Bendamustine Hydrochloride
3
merphos
2
dexamethasone acetate
2
dexamethasone 21-phosphate
2
auricularum
2
Vincristine
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Melphalan
2
Etoposide
2
Doxorubicin
2
Dexamethasone
2
Calcium Dobesilate
2
treosulfan
1
pirtobrutinib
1
palbociclib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Mantle-Cell
×
Axitinib
×
30 days
×
Clear all
No trials found.